Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mersana Therapeutics Inc.

    NASDAQ: MRSN · Real-Time Price · USD
    0.39
    0.00 (1.06%)
    At close: Jun 09, 2025, 3:59 PM

    Mersana Therapeutics Statistics

    Share Statistics

    Mersana Therapeutics has 124.63M shares outstanding. The number of shares has increased by 1.86% in one year.

    Shares Outstanding

    n/a
    		 124.63M

    Shares Change (YoY)

    n/a
    		 1.86%

    Shares Change (QoQ)

    n/a
    		 0.89%

    Owned by Institutions (%)

    n/a
    		 84.99%

    Shares Floating

    n/a
    		 96.84M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,812

    FTD / Avg. Volume

    n/a
    		 0.21%

    Short Selling Information

    The latest short interest is 12.78M, so 10.26% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.78M

    Short % of Shares Out

    n/a
    		 10.26%

    Short % of Float

    n/a
    		 11.2%

    Short Ratio (days to cover)

    n/a
    		 5.6

    Valuation Ratios

    The PE ratio is -2.53 and the forward PE ratio is -0.63. Mersana Therapeutics's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -2.53

    Forward PE

    n/a
    		 -0.63

    PS Ratio

    n/a
    		 4.33

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -18.43

    P/FCF Ratio

    n/a
    		 -2.12

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mersana Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.19, with a Debt / Equity ratio of -3.01.

    Current Ratio

    n/a
    		 2.19

    Quick Ratio

    n/a
    		 2.19

    Debt / Equity

    n/a
    		 -3.01

    Debt / EBITDA

    n/a
    		 -0.45

    Debt / FCF

    n/a
    		 -0.35

    Interest Coverage

    n/a
    		 -18.93

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $397,029.41

    Profits Per Employee

    n/a
    		 $-678,352.94

    Employee Count

    n/a
    		 102

    Asset Turnover

    n/a
    		 0.28

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 418K

    Effective Tax Rate

    n/a
    		 -0.61%

    Stock Price Statistics

    The stock price has increased by -81.78% in the last 52 weeks. The beta is 0.82, so Mersana Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.82

    52-Week Price Change

    n/a
    		 -81.78%

    50-Day Moving Average

    n/a
    		 0.35

    200-Day Moving Average

    n/a
    		 1.18

    Relative Strength Index (RSI)

    n/a
    		 53.77

    Average Volume (20 Days)

    n/a
    		 2,831,352

    Income Statement

    In the last 12 months, Mersana Therapeutics had revenue of 40.5M and earned -69.19M in profits. Earnings per share was -0.56.

    Revenue

    n/a
    		 40.5M

    Gross Profit

    n/a
    		 40.5M

    Operating Income

    n/a
    		 -73.34M

    Net Income

    n/a
    		 -69.19M

    EBITDA

    n/a
    		 -63.27M

    EBIT

    n/a
    		 -64.9M

    Earnings Per Share (EPS)

    n/a
    		 -0.56
    Full Income Statement

    Balance Sheet

    The company has 107.75M in cash and 28.6M in debt, giving a net cash position of 79.15M.

    Cash & Cash Equivalents

    n/a
    		 107.75M

    Total Debt

    n/a
    		 28.6M

    Net Cash

    n/a
    		 79.15M

    Retained Earnings

    n/a
    		 -895.55M

    Total Assets

    n/a
    		 112.47M

    Working Capital

    n/a
    		 48.03M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -82.34M and capital expenditures -132K, giving a free cash flow of -82.47M.

    Operating Cash Flow

    n/a
    		 -82.34M

    Capital Expenditures

    n/a
    		 -132K

    Free Cash Flow

    n/a
    		 -82.47M

    FCF Per Share

    n/a
    		 -0.67
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -181.09% and -170.86%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -181.09%

    Pretax Margin

    n/a
    		 -169.82%

    Profit Margin

    n/a
    		 -170.86%

    EBITDA Margin

    n/a
    		 -156.24%

    EBIT Margin

    n/a
    		 -181.09%

    FCF Margin

    n/a
    		 -203.65%

    Dividends & Yields

    MRSN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MRSN is $5, which is 1182.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 1182.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -12.5

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist